Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)
DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)
DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays
巴克萊維持DJ Blueprint Medicines的同等權重
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
February 18, 2021 09:57 ET (14:57 GMT)
2021年2月18日09:57美國東部時間(格林尼治標準時間14:57)
DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
巴克萊將DJ Blueprint藥品目標價從每股90.00美元上調至95.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
February 18, 2021 09:57 ET (14:57 GMT)
2021年2月18日09:57美國東部時間(格林尼治標準時間14:57)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧